Cancer Therapy News and Research

RSS

New approach to immunotherapy provokes a robust anti-tumor immune response in preclinical models

A new approach to cancer immunotherapy that uses one type of immune cell to kill another-;rather than directly attacking the cancer-;provokes a robust anti-tumor immune response that shrinks ovarian, lung, and pancreatic tumors in preclinical disease models, according to researchers at the Icahn School of Medicine at Mount Sinai in New York.

25 Oct 2022

AI model predicts the likelihood of unplanned hospitalization during radiation treatments for cancer

An artificial intelligence (AI) model developed by researchers can predict the likelihood that a patient may have an unplanned hospitalization during their radiation treatments for cancer.

24 Oct 2022

Study develops a strategy to noninvasively track tumor-associated macrophages

A Ludwig Cancer Research study has developed a strategy to noninvasively track immune cells known as macrophages within brain and breast tumors in living mice.

19 Oct 2022

Newly identified process keeps some immune cells on their toes

Cancer cells use an unusual mechanism to migrate into new tissue and form metastases there. The same process probably also keeps some immune cells on their toes.

14 Oct 2022

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

A study led by researchers at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) has determined the role that fibroblasts, the cells that contribute to tissue formation, play in a tumor's ability to generate resistance to the most common biological treatment for HER2.

14 Oct 2022

Exploring the possibilities of plasma-based therapies for cancer

Exploring the possibilities of atmospheric-pressure plasmas to develop and consolidate new medical therapies is the main objective of the PlasTHER network, an initiative funded by the European Union under the COST Actions.

11 Oct 2022

Giving immunotherapy before targeted therapy improves survival in patients with advanced melanoma

A clinical trial led by clinicians at Georgetown Lombardi Comprehensive Cancer Center showed a remarkable 20 percent advantage in the two-year overall survival rate for people with advanced melanoma who first received immunotherapy (72 percent survival rate) versus those who initially got targeted therapies (52 percent survival rate).

27 Sep 2022

Prevention of cardiovascular disease is important in cancer patients

With the increasing number of cancer survivors, the medical community is becoming increasingly aware of a hitherto less noticed health risk: cancer therapy-related cardiovascular disease.

26 Sep 2022

Cancer survival rate rises in the US

In a recent article by the American Association for Cancer Research (AACR), the researchers highlighted basic, translational, and clinical cancer research and cancer-related population sciences in the 12th edition of its annual Cancer Progress Report.

25 Sep 2022

Study explores the effect of age-associated B cells on COVID-19 vaccine-induced immunity

In a new study, a team of researchers explored the effect of immune checkpoint blockade (ICB)-induced expansion of age-associated B cells (ABCs) on COVID-19 vaccine-derived humoral immunity in patients with cancer and inborn errors of immunity (IEI).

22 Sep 2022

Public-private collaboration receives grant for research on microbiota-boosted cancer therapy

Health~Holland has awarded close to € 800,000 to a public-private partnership between UMC Utrecht, Artizan Biosciences, Inc. (USA) and MicroViable Therapeutics (Spain) to unravel how the intestinal microbiota can be exploited to boost cancer immunotherapy and limit therapy side-effects.

21 Sep 2022

Study finds telomeres can set damage thresholds for cancer cells above which they cannot continue to divide

A recent study hypothesized that ALT might compromise telomere integrity if not restricted appropriately.

21 Sep 2022

Combination of three existing drugs extends survival in mouse models of lethal brain cancer

A Ludwig Cancer Research study has identified a combination of three existing drugs that significantly extends survival in mouse models of the lethal brain cancer glioblastoma multiforme (GBM).

20 Sep 2022

Discovery of novel pathway offers a potential solution for preventing cancer chemo-resistance

Researchers have uncovered a novel pathway that explains how cancer cells become resistant to chemotherapies, which in turn offers a potential solution for preventing chemo-resistance.

20 Sep 2022

Research opens a new avenue for the treatment of cancer by phototherapy

One approach to treating cancer is photodynamic therapy using photo-uncaging systems, in which light is used to activate a cancer-fighting agent in situ at the tumor.

20 Sep 2022

Overload of stress granules enables the growth of obesity-related pancreatic cancer

Obesity is a known risk factor for at least 13 types of cancer, in part because it creates ever-present inflammatory state. For years, one researcher has wondered if there's more to the story than inflammation.

20 Sep 2022

New SIO-ASCO practice guideline addresses the use of integrative therapies for cancer pain management

A new joint practice guideline from the Society for Integrative Oncology and the American Society of Clinical Oncology, Inc. has been published to address gaps in healthcare providers' knowledge of how to safely and effectively treat common cancer symptoms and side effects using integrative medicine approaches.

19 Sep 2022

Is aspirin linked to higher rates of survival for cancer patients?

Researchers discussed the existing evidence on the use of acetylsalicylic acid (aspirin) in cancer treatment.

19 Sep 2022

Final results of the PATHFINDER study by GRAIL on multi-cancer early detection tests announced

A new press release announced the results of their interventional PATHFINDER study on the early detection of cancer using multi-cancer early detection (MCED) blood tests.

13 Sep 2022

Patients with high-risk melanoma benefit from immunotherapy prior to surgery

Patients with high-risk melanoma who received the immunotherapy drug pembrolizumab both before and after surgery to remove cancerous tissue had a significantly lower risk of their cancer recurring than similar patients who received the drug only after surgery.

12 Sep 2022

Cancer Therapy News and Research

New approach to immunotherapy provokes a robust anti-tumor immune response in preclinical models

AI model predicts the likelihood of unplanned hospitalization during radiation treatments for cancer

Study develops a strategy to noninvasively track tumor-associated macrophages

Newly identified process keeps some immune cells on their toes

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

Exploring the possibilities of plasma-based therapies for cancer

Giving immunotherapy before targeted therapy improves survival in patients with advanced melanoma

Prevention of cardiovascular disease is important in cancer patients

Cancer survival rate rises in the US

Study explores the effect of age-associated B cells on COVID-19 vaccine-induced immunity

Public-private collaboration receives grant for research on microbiota-boosted cancer therapy

Study finds telomeres can set damage thresholds for cancer cells above which they cannot continue to divide

Combination of three existing drugs extends survival in mouse models of lethal brain cancer

Discovery of novel pathway offers a potential solution for preventing cancer chemo-resistance

Research opens a new avenue for the treatment of cancer by phototherapy

Overload of stress granules enables the growth of obesity-related pancreatic cancer

New SIO-ASCO practice guideline addresses the use of integrative therapies for cancer pain management

Is aspirin linked to higher rates of survival for cancer patients?

Final results of the PATHFINDER study by GRAIL on multi-cancer early detection tests announced

Patients with high-risk melanoma benefit from immunotherapy prior to surgery

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Latest News